Innospec (IOSP) Financials

$80.46 +0.78 (+0.97%)

As of 02:52 PM Eastern

Annual Income Statements for Innospec

This table shows Innospec's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	120	81	62	85	112	29	93	133	139	36	117
Consolidated Net Income / (Loss)	120	81	62	85	112	29	93	133	139	36	117
Net Income / (Loss) Continuing Operations	120	81	62	85	112	29	93	133	139	36	117
Total Pre-Tax Income	152	103	128	132	150	40	134	185	174	41	138
Total Operating Income	156	98	125	134	150	34	132	187	162	178	130
Total Gross Profit	346	332	403	435	466	343	435	587	591	543	492
Total Revenue	1,012	883	1,307	1,477	1,513	1,193	1,483	1,964	1,949	1,845	1,778
Operating Revenue	1,012	883	1,307	1,477	1,513	1,193	1,483	1,964	1,949	1,845	1,778
Total Cost of Revenue	666	551	904	1,042	1,047	850	1,049	1,377	1,358	1,303	1,286
Operating Cost of Revenue	666	551	904	1,042	1,047	850	1,049	1,377	1,358	1,303	1,286
Total Operating Expenses	190	234	278	302	316	309	303	399	430	365	363
Selling, General & Admin Expense	207	217	244	261	281	237	267	361	381	305	285
Research & Development Expense	25	25	31	33	35	31	37	39	49	57	51
Impairment Charge	-	-	-	0.00	0.00	20	0.00	0.00	0.00	0.00	42
Restructuring Charge	-	0.00	0.00	7.10	0.00	21	-	-	0.00	0.00	0.90
Other Special Charges / (Income)	-41	-9.40	-	-	-	0.00	-1.80	0.00	0.00	3.20	-16
Total Other Income / (Expense), net	-4.00	4.90	3.10	-1.90	0.50	6.00	2.30	-2.70	13	-137	8.60
Interest & Investment Income	-4.00	-3.20	-8.20	-6.90	-4.80	-1.80	-1.50	-1.10	2.30	9.30	9.20
Other Income / (Expense), net	0.00	8.10	11	5.00	5.30	7.80	3.80	-1.60	11	-146	-0.60
Income Tax Expense	33	22	66	47	38	11	41	52	35	5.60	22
Basic Earnings per Share	$4.96	$3.39	$2.56	$3.48	$4.58	$1.17	$3.78	$5.37	$5.60	$1.43	$4.69
Weighted Average Basic Shares Outstanding	24.11M	24.00M	24.15M	24.40M	24.48M	24.56M	24.65M	24.79M	24.85M	24.93M	24.88M
Diluted Earnings per Share	$4.86	$3.33	$2.52	$3.45	$4.54	$1.16	$3.75	$5.32	$5.56	$1.42	$4.67
Weighted Average Diluted Shares Outstanding	24.61M	24.44M	24.49M	24.60M	24.73M	24.78M	24.85M	24.98M	25.02M	25.12M	24.99M
Weighted Average Basic & Diluted Shares Outstanding	24.10M	24M	24.10M	24.40M	24.51M	24.60M	24.77M	24.77M	24.87M	24.96M	24.78M
Cash Dividends to Common per Share	$0.61	$0.67	$0.77	$0.89	$1.02	$1.04	$1.16	$1.28	$1.41	$1.55	$1.71

This table shows Innospec's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	39	38	41	31	33	-70	33	24	13	47	30
Consolidated Net Income / (Loss)	39	38	41	31	33	-70	34	24	13	47	31
Net Income / (Loss) Continuing Operations	39	38	41	31	33	-70	34	24	13	47	31
Total Pre-Tax Income	48	45	55	44	45	-103	45	32	12	50	40
Total Operating Income	42	45	51	41	46	41	43	34	5.90	47	37
Total Gross Profit	137	156	156	127	124	136	125	123	117	127	124
Total Revenue	464	495	500	435	443	467	441	440	442	456	453
Operating Revenue	464	495	500	435	443	467	441	440	442	456	453
Total Cost of Revenue	327	339	345	308	319	331	316	317	325	328	330
Operating Cost of Revenue	327	339	345	308	319	331	316	317	325	328	330
Total Operating Expenses	95	111	105	86	79	95	83	89	111	81	87
Selling, General & Admin Expense	84	102	91	72	64	81	69	75	72	69	79
Research & Development Expense	12	8.90	14	14	14	13	13	14	14	11	13
Other Special Charges / (Income)	0.00	-	0.70	0.60	0.60	1.30	0.60	0.70	-18	0.30	-4.70
Total Other Income / (Expense), net	5.60	0.80	4.80	3.00	-0.80	-144	2.70	-2.40	5.60	3.50	3.40
Interest & Investment Income	0.80	1.50	2.10	2.10	2.70	2.40	2.40	2.70	2.20	1.90	0.80
Other Income / (Expense), net	4.80	-0.70	2.70	0.90	-3.50	-146	0.30	-5.10	3.40	1.60	2.60
Income Tax Expense	8.30	7.50	14	13	11	-32	12	8.40	-1.40	2.90	9.10
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	0.80	-	-	-	0.40
Basic Earnings per Share	$1.58	$1.52	$1.66	$1.25	$1.34	($2.82)	$1.31	$0.94	$0.52	$1.92	$1.23
Weighted Average Basic Shares Outstanding	24.87M	24.85M	24.89M	24.94M	24.94M	24.93M	24.97M	24.94M	24.83M	24.88M	24.78M
Diluted Earnings per Share	$1.57	$1.50	$1.65	$1.24	$1.33	($2.80)	$1.31	$0.94	$0.52	$1.90	$1.22
Weighted Average Diluted Shares Outstanding	25.01M	25.02M	25.07M	25.10M	25.10M	25.12M	25.10M	25.04M	24.91M	24.99M	24.84M
Weighted Average Basic & Diluted Shares Outstanding	24.87M	24.87M	24.93M	24.94M	24.94M	24.96M	24.96M	24.83M	24.78M	24.78M	24.63M

This table details how cash moves in and out of Innospec's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	95	-35	-12	33	-47	30	37	5.30	57	86	3.30
Net Cash From Operating Activities	118	106	83	105	162	146	93	82	207	185	138
Net Cash From Continuing Operating Activities	118	106	83	105	162	146	93	82	207	185	138
Net Income / (Loss) Continuing Operations	120	81	62	85	112	29	93	133	139	36	117
Consolidated Net Income / (Loss)	120	81	62	85	112	29	93	133	139	36	117
Depreciation Expense	35	38	50	50	48	46	43	40	39	44	44
Non-Cash Adjustments To Reconcile Net Income	2.60	-1.50	3.20	0.60	0.50	24	-0.90	4.20	4.70	164	37
Changes in Operating Assets and Liabilities, net	-39	-12	-33	-30	1.30	48	-42	-96	24	-58	-59
Net Cash From Investing Activities	15	-209	-30	-36	-31	-30	-36	-42	-112	-62	-75
Net Cash From Continuing Investing Activities	15	-209	-30	-36	-31	-30	-36	-42	-112	-62	-75
Purchase of Property, Plant & Equipment	-26	-17	-28	-30	-31	-30	-39	-42	-77	-62	-76
Acquisitions	0.00	-197	-4.20	-5.40	-	-	0.00	0.00	-	-	-0.70
Sale of Property, Plant & Equipment	-	-	-	-	0.00	0.00	2.90	0.20	0.10	0.50	1.10
Net Cash From Financing Activities	-37	70	-66	-36	-178	-87	-20	-34	-39	-35	-64
Net Cash From Continuing Financing Activities	-37	70	-66	-36	-178	-87	-20	-34	-39	-35	-64
Repayment of Debt	-14	-22	-53	-24	-175	-76	-0.60	-0.10	-3.70	-0.30	0.00
Repurchase of Common Equity	-15	-8.40	-1.10	-1.40	-2.40	-2.10	-0.80	-5.90	-1.10	-0.70	-24
Payment of Dividends	-15	-60	-19	-22	-25	-26	-29	-32	-35	-39	-42
Issuance of Common Equity	1.30	2.10	6.80	1.10	1.20	2.30	10	4.00	0.90	4.50	2.40
Effect of Exchange Rate Changes	-1.10	-0.90	1.60	-0.30	-	0.20	-0.50	-0.60	0.10	-1.70	4.00

This table details how cash moves in and out of Innospec's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	41	-3.50	66	-30	64	-15	11	-33	4.20	22	-3.40
Net Cash From Operating Activities	58	72	81	4.70	74	26	28	9.30	39	61	18
Net Cash From Continuing Operating Activities	58	72	81	4.80	73	26	28	9.30	39	61	18
Net Income / (Loss) Continuing Operations	39	38	41	31	33	-70	33	24	13	47	30
Consolidated Net Income / (Loss)	39	38	41	31	33	-70	33	24	13	47	30
Depreciation Expense	9.90	10	10	11	11	11	11	11	12	9.40	9.90
Non-Cash Adjustments To Reconcile Net Income	1.20	1.30	1.20	1.40	1.10	157	3.80	3.40	28	2.20	-3.30
Changes in Operating Assets and Liabilities, net	7.80	23	28	-39	28	-71	-19	-29	-14	2.40	-19
Net Cash From Investing Activities	-17	-56	-14	-15	-12	-21	-16	-16	-24	-19	-14
Net Cash From Continuing Investing Activities	-17	-56	-14	-15	-12	-21	-16	-16	-24	-19	-14
Purchase of Property, Plant & Equipment	-17	-21	-14	-15	-12	-21	-16	-17	-22	-21	-14
Acquisitions	-	-35	-	-	-	-	0.00	-	-2.00	1.30	0.00
Sale of Property, Plant & Equipment	-	0.10	0.10	0.10	0.10	0.20	0.10	0.40	-0.10	0.70	0.30
Net Cash From Financing Activities	0.20	-20	0.50	-19	0.90	-18	-3.80	-29	-11	-21	-6.60
Net Cash From Continuing Financing Activities	0.20	-20	0.50	-19	0.90	-18	-3.80	-29	-11	-21	-6.60
Repayment of Debt	0.10	-2.30	-	-	-	-	0.00	-	-	-	0.00
Repurchase of Common Equity	-	-0.10	-0.40	-0.30	-	-	-4.80	-8.50	-11	-	-7.10
Payment of Dividends	-	-18	-	-	-	-20	0.00	-	-	-22	0.00
Issuance of Common Equity	0.10	-0.10	0.90	0.70	0.90	2.00	1.00	0.60	-0.20	1.00	0.50
Effect of Exchange Rate Changes	-0.30	0.30	-0.40	-0.30	0.90	-1.90	1.60	2.40	-0.10	0.10	-0.70

This table presents Innospec's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	1,029	1,181	1,410	1,473	1,469	1,397	1,571	1,604	1,707	1,735	1,832
Total Current Assets	459	441	0.00	664	630	566	728	873	886	957	1,005
Cash & Equivalents	137	102	-	123	76	105	142	147	204	289	293
Accounts Receivable	137	154	-	280	292	221	285	335	360	342	342
Inventories, net	160	174	-	248	245	220	278	373	300	301	329
Prepaid Expenses	6.10	6.20	-	12	15	15	18	14	19	21	20
Current Deferred & Refundable Income Taxes	12	4.80	-	1.50	2.50	4.20	5.80	3.30	2.80	3.10	13
Other Current Assets	1.80	0.00	-	0.00	0.80	0.40	0.40	0.40	0.60	0.60	7.30
Plant, Property, & Equipment, net	76	157	0.00	196	199	211	214	221	268	270	286
Total Noncurrent Assets	494	583	362	613	640	620	628	510	553	508	542
Goodwill	267	375	362	365	363	371	364	359	399	383	399
Intangible Assets	169	144	-	136	114	75	58	45	57	65	68
Noncurrent Deferred & Refundable Income Taxes	1.40	15	-	8.80	9.10	7.60	6.40	5.90	10	9.40	14
Other Noncurrent Operating Assets	0.90	0.80	-	7.20	38	48	40	52	51	49	61
Total Liabilities & Shareholders' Equity	1,029	1,181	843	1,473	1,469	1,397	1,571	1,604	1,707	1,735	1,832
Total Liabilities	423	528	49	648	550	453	538	563	558	519	500
Total Current Liabilities	206	183	5.20	297	304	252	337	406	372	371	360
Short-Term Debt	55	12	-	23	1.00	-	-	-	-	0.00	7.00
Accounts Payable	52	60	-	127	122	99	149	165	164	164	175
Accrued Expenses	84	95	-	132	154	130	167	203	186	169	152
Current Deferred & Payable Income Tax Liabilities	7.90	9.40	-	8.60	10	5.50	3.70	18	3.80	20	5.30
Other Current Liabilities	6.40	6.70	5.20	5.90	16	18	18	19	18	19	21
Total Noncurrent Liabilities	217	345	43	351	246	200	201	158	186	147	139
Asset Retirement Reserve & Litigation Obligation	31	33	41	44	44	52	51	52	57	55	60
Noncurrent Deferred & Payable Income Tax Liabilities	42	35	2.50	62	66	63	77	40	47	24	19
Noncurrent Employee Benefit Liabilities	9.20	14	-	16	18	21	18	12	13	13	13
Other Noncurrent Operating Liabilities	0.50	1.00	-	2.10	24	3.50	25	33	57	55	47
Total Equity & Noncontrolling Interests	605	654	794	826	919	945	1,033	1,040	1,150	1,216	1,333
Total Preferred & Common Equity	605	654	794	825	919	944	1,032	1,038	1,147	1,211	1,326
Total Common Equity	605	654	794	825	919	944	1,032	1,038	1,147	1,211	1,326
Common Stock	311	315	794	325	331	336	347	354	361	370	377
Retained Earnings	496	562	-	668	756	759	823	924	1,028	1,025	1,099
Treasury Stock	-92	-98	-	-93	-93	-93	-91	-95	-94	-93	-115
Accumulated Other Comprehensive Income / (Loss)	-111	-126	-	-76	-74	-57	-47	-145	-148	-91	-35
Noncontrolling Interest	0.30	0.30	-	0.50	0.40	0.50	0.60	2.40	2.50	4.90	6.80

This table presents Innospec's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	1,669	1,624	1,611	1,619	1,733	1,700	1,798	1,775	1,806	1,799	1,820
Total Current Assets	846	875	855	864	913	877	966	977	970	989	999
Cash & Equivalents	101	148	166	207	270	240	304	300	267	271	289
Accounts Receivable	343	342	311	305	318	300	328	344	336	350	354
Inventories, net	382	366	357	332	304	314	319	315	337	345	322
Prepaid Expenses	7.40	15	11	7.70	15	9.70	9.20	16	14	8.70	17
Current Deferred & Refundable Income Taxes	14	3.60	9.80	11	4.40	12	5.10	1.00	12	11	11
Other Current Assets	0.40	0.40	0.70	1.40	0.90	1.00	0.60	1.40	4.40	4.10	6.80
Plant, Property, & Equipment, net	207	234	242	245	269	272	278	277	296	279	286
Total Noncurrent Assets	616	516	514	510	551	552	554	520	541	532	535
Goodwill	352	360	361	358	398	388	392	388	398	400	399
Intangible Assets	44	47	47	48	58	61	64	73	78	63	69
Noncurrent Deferred & Refundable Income Taxes	5.70	5.90	5.90	5.90	10	10	11	8.60	8.90	8.90	13
Other Noncurrent Operating Assets	53	54	52	49	50	55	49	49	56	60	54
Total Liabilities & Shareholders' Equity	1,669	1,624	1,611	1,619	1,733	1,700	1,798	1,775	1,806	1,799	1,820
Total Liabilities	577	544	516	491	547	504	550	509	505	497	468
Total Current Liabilities	381	382	365	344	365	333	373	358	337	356	335
Short-Term Debt	-	-	-	-	-	-	-	-	-	-	2.70
Accounts Payable	174	178	158	146	166	148	169	170	149	162	139
Accrued Expenses	174	164	175	165	164	143	170	148	164	167	169
Current Deferred & Payable Income Tax Liabilities	15	20	14	15	17	23	16	22	3.90	5.60	4.30
Other Current Liabilities	19	20	19	18	18	20	19	19	21	21	20
Total Noncurrent Liabilities	196	162	151	146	182	172	177	151	167	140	133
Asset Retirement Reserve & Litigation Obligation	50	52	53	51	57	57	59	57	64	63	61
Noncurrent Deferred & Payable Income Tax Liabilities	76	41	41	41	45	46	47	23	24	14	18
Noncurrent Employee Benefit Liabilities	16	13	12	12	13	13	13	13	14	14	13
Other Noncurrent Operating Liabilities	34	35	33	31	56	56	58	58	66	49	41
Total Equity & Noncontrolling Interests	1,092	1,081	1,095	1,128	1,186	1,196	1,248	1,266	1,302	1,303	1,352
Total Preferred & Common Equity	1,089	1,078	1,092	1,125	1,184	1,193	1,243	1,260	1,295	1,297	1,345
Total Common Equity	1,089	1,078	1,092	1,125	1,184	1,193	1,243	1,260	1,295	1,297	1,345
Common Stock	353	355	357	359	363	365	367	371	373	374	378
Retained Earnings	915	957	969	1,008	1,070	1,082	1,115	1,058	1,061	1,073	1,130
Treasury Stock	-95	-94	-94	-94	-93	-93	-93	-97	-105	-115	-121
Accumulated Other Comprehensive Income / (Loss)	-83	-141	-140	-148	-155	-161	-145	-72	-33	-35	-41
Noncontrolling Interest	2.50	2.40	2.60	2.70	2.60	3.30	4.20	5.70	6.10	5.90	7.20

This table displays calculated financial ratios and metrics derived from Innospec's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.35%	-12.73%	47.93%	13.02%	2.46%	-21.16%	24.33%	32.38%	-0.76%	-5.31%	-3.65%
EBITDA Growth	33.54%	-24.60%	29.29%	0.75%	7.82%	-56.85%	104.11%	26.43%	-6.38%	-64.33%	128.78%
EBIT Growth	36.75%	-31.99%	28.22%	1.61%	12.06%	-73.26%	227.47%	36.64%	-7.32%	-81.46%	304.08%
NOPAT Growth	43.75%	-36.86%	-22.12%	42.99%	29.69%	-78.21%	275.61%	47.47%	-4.49%	19.26%	-28.87%
Net Income Growth	42.09%	-31.97%	-23.99%	37.54%	32.00%	-74.42%	224.39%	42.86%	4.59%	-74.41%	227.53%
EPS Growth	43.79%	-31.48%	-24.32%	36.90%	31.59%	-74.45%	223.28%	41.87%	4.51%	-74.46%	228.87%
Operating Cash Flow Growth	11.19%	-10.74%	-21.61%	26.84%	54.05%	-9.72%	-36.12%	-12.34%	153.73%	-11.00%	-25.04%
Free Cash Flow Firm Growth	-24,714.42%	67.78%	703.29%	-189.79%	123.71%	-51.44%	16.30%	93.07%	-42.57%	126.40%	-106.46%
Invested Capital Growth	176.89%	26.39%	-62.05%	191.60%	-1.09%	-3.85%	2.61%	0.24%	5.89%	-2.01%	13.00%
Revenue Q/Q Growth	-4.23%	-0.92%	9.74%	2.87%	-0.28%	-3.81%	4.93%	5.22%	-0.81%	-1.49%	-0.63%
EBITDA Q/Q Growth	-2.94%	-4.12%	9.18%	0.00%	0.00%	-1.80%	-4.70%	4.39%	-0.19%	-66.26%	737.38%
EBIT Q/Q Growth	-4.46%	-5.60%	9.74%	1.09%	0.26%	-2.35%	-6.79%	6.97%	-0.81%	-82.35%	626.12%
NOPAT Q/Q Growth	1.86%	-13.11%	-29.60%	46.45%	10.25%	1.35%	-6.27%	0.31%	8.23%	11.50%	26.17%
Net Income Q/Q Growth	3.11%	-10.36%	-30.33%	42.14%	10.54%	4.36%	-8.28%	1.22%	9.70%	-75.24%	9,816.67%
EPS Q/Q Growth	3.85%	-10.24%	-30.39%	41.39%	10.46%	7.41%	-8.76%	0.95%	9.45%	-75.17%	15,666.67%
Operating Cash Flow Q/Q Growth	-14.29%	-7.94%	54.00%	27.00%	-6.59%	-0.14%	12.83%	13.31%	-2.81%	-20.20%	34.80%
Free Cash Flow Firm Q/Q Growth	-811.55%	-215.65%	390.16%	-58,588.86%	-29.63%	-14.18%	28.06%	182.47%	-59.76%	50.23%	-580.56%
Invested Capital Q/Q Growth	3.87%	29.81%	-65.90%	-6.48%	-0.18%	0.99%	-1.41%	-9.90%	2.71%	-1.79%	1.48%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	34.18%	37.62%	30.86%	29.45%	30.81%	28.72%	29.32%	29.88%	30.33%	29.42%	27.69%
EBITDA Margin	18.92%	16.35%	14.29%	12.74%	13.40%	7.33%	12.04%	11.50%	10.85%	4.09%	9.70%
Operating Margin	15.44%	11.12%	9.57%	9.04%	9.91%	2.82%	8.91%	9.54%	8.29%	9.64%	7.28%
EBIT Margin	15.44%	12.03%	10.43%	9.38%	10.26%	3.48%	9.16%	9.46%	8.83%	1.73%	7.25%
Profit (Net Income) Margin	11.80%	9.20%	4.73%	5.76%	7.41%	2.41%	6.28%	6.77%	7.14%	1.93%	6.56%
Tax Burden Percent	78.46%	78.86%	48.24%	64.59%	74.60%	72.29%	69.27%	72.05%	79.76%	86.41%	84.43%
Interest Burden Percent	97.44%	96.99%	93.98%	95.02%	96.91%	95.66%	98.90%	99.41%	101.34%	129.15%	107.14%
Effective Tax Rate	21.54%	21.14%	51.76%	35.41%	25.40%	27.71%	30.73%	27.95%	20.24%	13.59%	15.57%
Return on Invested Capital (ROIC)	27.60%	10.48%	10.59%	14.06%	12.31%	2.75%	10.40%	15.12%	14.02%	16.42%	11.08%
ROIC Less NNEP Spread (ROIC-NNEP)	30.30%	14.01%	9.63%	14.68%	13.34%	-6.68%	8.94%	16.47%	8.20%	64.34%	8.55%
Return on Net Nonoperating Assets (RNNOA)	-6.28%	2.44%	-2.06%	-3.57%	0.55%	0.33%	-0.99%	-2.30%	-1.31%	-13.41%	-1.93%
Return on Equity (ROE)	21.32%	12.91%	8.54%	10.50%	12.86%	3.08%	9.41%	12.83%	12.70%	3.01%	9.15%
Cash Return on Invested Capital (CROIC)	-66.27%	-12.84%	100.55%	-83.80%	13.41%	6.68%	7.82%	14.89%	8.30%	18.45%	-1.13%
Operating Return on Assets (OROA)	15.41%	9.62%	10.52%	9.61%	10.55%	2.90%	9.16%	11.70%	10.40%	1.85%	7.23%
Return on Assets (ROA)	11.78%	7.36%	4.77%	5.90%	7.63%	2.00%	6.27%	8.38%	8.40%	2.07%	6.54%
Return on Common Equity (ROCE)	9.48%	12.91%	8.53%	10.49%	12.86%	3.08%	9.41%	12.81%	12.67%	3.00%	9.11%
Return on Equity Simple (ROE_SIMPLE)	19.75%	12.44%	7.78%	10.30%	12.22%	3.04%	9.02%	12.81%	12.13%	2.94%	0.00%
Net Operating Profit after Tax (NOPAT)	123	77	60	86	112	24	92	135	129	154	109
NOPAT Margin	12.11%	8.77%	4.61%	5.84%	7.39%	2.04%	6.17%	6.87%	6.61%	8.33%	6.15%
Net Nonoperating Expense Percent (NNEP)	-2.70%	-3.53%	0.97%	-0.62%	-1.03%	9.43%	1.46%	-1.35%	5.82%	-47.93%	2.53%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	12.97%	11.21%	12.64%	8.16%
Cost of Revenue to Revenue	65.82%	62.38%	69.14%	70.55%	69.19%	71.28%	70.68%	70.12%	69.67%	70.58%	72.31%
SG&A Expenses to Revenue	20.42%	24.53%	18.69%	17.67%	18.56%	19.86%	18.01%	18.37%	19.90%	17.02%	16.03%
R&D to Revenue	2.50%	2.88%	2.40%	2.26%	2.34%	2.59%	2.52%	1.97%	2.14%	2.59%	2.87%
Operating Expenses to Revenue	18.74%	26.50%	21.30%	20.41%	20.90%	25.90%	20.41%	20.34%	22.04%	19.78%	20.41%
Earnings before Interest and Taxes (EBIT)	156	106	136	139	155	42	136	186	172	32	129
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	192	144	187	188	203	88	179	226	211	75	173
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.94	2.29	1.98	1.71	2.60	2.26	2.09	2.39	2.64	2.27	1.43
Price to Tangible Book Value (P/TBV)	6.97	11.14	3.63	4.35	5.41	4.29	3.53	3.91	4.38	3.60	2.21
Price to Revenue (P/Rev)	1.16	1.69	1.20	0.95	1.58	1.79	1.45	1.26	1.55	1.49	1.07
Price to Earnings (P/E)	9.84	18.40	25.42	16.55	21.31	74.39	23.17	18.66	21.76	77.11	16.26
Dividend Yield	1.25%	1.07%	1.18%	1.55%	1.05%	1.20%	1.33%	1.28%	1.16%	1.41%	2.23%
Earnings Yield	10.16%	5.43%	3.93%	6.04%	4.69%	1.34%	4.32%	5.36%	4.60%	1.30%	6.15%
Enterprise Value to Invested Capital (EV/IC)	1.88	2.02	5.02	1.64	2.63	2.37	2.26	2.62	2.99	2.65	1.54
Enterprise Value to Revenue (EV/Rev)	1.21	1.89	1.20	1.01	1.57	1.73	1.36	1.19	1.45	1.33	0.91
Enterprise Value to EBITDA (EV/EBITDA)	6.39	11.55	8.41	7.95	11.71	23.53	11.29	10.35	13.36	32.64	9.38
Enterprise Value to EBIT (EV/EBIT)	7.83	15.69	11.52	10.80	15.31	49.62	14.84	12.58	16.42	77.14	12.55
Enterprise Value to NOPAT (EV/NOPAT)	9.98	21.54	26.05	17.34	21.24	84.52	22.03	17.32	21.92	16.01	14.80
Enterprise Value to Operating Cash Flow (EV/OCF)	10.36	15.81	18.99	14.25	14.70	14.11	21.63	28.60	13.63	13.34	11.70
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	2.74	0.00	19.50	34.81	29.30	17.59	37.03	14.25	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.31	0.42	0.00	0.26	0.07	0.03	0.00	0.00	0.00	0.00	0.01
Long-Term Debt to Equity	0.22	0.40	0.00	0.23	0.06	0.03	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.21	0.17	-0.21	-0.24	0.04	-0.05	-0.11	-0.14	-0.16	-0.21	-0.23
Leverage Ratio	1.81	1.76	1.79	1.78	1.69	1.54	1.50	1.53	1.51	1.46	1.40
Compound Leverage Factor	1.76	1.70	1.68	1.69	1.63	1.47	1.48	1.52	1.53	1.88	1.50
Debt to Total Capital	23.82%	29.48%	0.00%	20.35%	6.14%	2.97%	0.00%	0.00%	0.00%	0.00%	0.52%
Short-Term Debt to Total Capital	6.96%	1.28%	0.00%	2.24%	0.10%	0.00%	0.00%	0.00%	0.00%	0.00%	0.52%
Long-Term Debt to Total Capital	16.86%	28.20%	0.00%	18.11%	6.04%	2.97%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.04%	0.03%	0.00%	0.05%	0.04%	0.05%	0.06%	0.23%	0.22%	0.40%	0.51%
Common Equity to Total Capital	76.14%	70.49%	100.00%	79.60%	93.82%	96.98%	99.94%	99.77%	99.78%	99.60%	98.97%
Debt to EBITDA	0.99	1.89	0.00	1.12	0.30	0.33	0.00	0.00	0.00	0.00	0.04
Net Debt to EBITDA	0.25	1.19	0.00	0.47	-0.08	-0.87	0.00	0.00	0.00	0.00	-1.66
Long-Term Debt to EBITDA	0.70	1.81	0.00	1.00	0.29	0.33	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	1.54	3.53	0.00	2.45	0.54	1.19	0.00	0.00	0.00	0.00	0.06
Net Debt to NOPAT	0.39	2.21	0.00	1.02	-0.14	-3.14	0.00	0.00	0.00	0.00	-2.61
Long-Term Debt to NOPAT	1.09	3.38	0.00	2.18	0.53	1.19	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	4.12	3.67	20.63	3.55	4.97	4.81	4.67	5.41	5.93	5.53	4.74
Noncontrolling Interest Sharing Ratio	55.52%	0.05%	0.02%	0.03%	0.05%	0.05%	0.06%	0.14%	0.22%	0.31%	0.46%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.23	2.41	0.00	2.24	2.08	2.24	2.16	2.15	2.38	2.58	2.79
Quick Ratio	1.35	1.40	0.00	1.36	1.21	1.29	1.27	1.19	1.52	1.70	1.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-294	-95	572	-514	122	59	69	133	76	173	-11
Operating Cash Flow to CapEx	451.15%	639.39%	295.36%	348.51%	521.29%	491.25%	257.46%	194.06%	268.87%	298.54%	185.89%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.00	0.80	1.01	1.02	1.03	0.83	1.00	1.24	1.18	1.07	1.00
Accounts Receivable Turnover	0.00	6.05	0.00	0.00	5.29	4.65	5.86	6.34	5.61	5.26	5.20
Inventory Turnover	0.00	3.30	0.00	0.00	4.25	3.66	4.21	4.23	4.03	4.33	4.08
Fixed Asset Turnover	0.00	7.57	0.00	0.00	7.66	5.83	6.98	9.02	7.97	6.86	6.40
Accounts Payable Turnover	0.00	9.86	0.00	0.00	8.42	7.71	8.48	8.77	8.26	7.96	7.60
Days Sales Outstanding (DSO)	0.00	60.28	0.00	0.00	68.95	78.53	62.24	57.54	65.03	69.37	70.21
Days Inventory Outstanding (DIO)	0.00	110.51	0.00	0.00	85.86	99.71	86.61	86.24	90.49	84.22	89.48
Days Payable Outstanding (DPO)	0.00	37.02	0.00	0.00	43.36	47.36	43.06	41.62	44.21	45.87	48.05
Cash Conversion Cycle (CCC)	0.00	133.77	0.00	0.00	111.44	130.87	105.79	102.16	111.31	107.72	111.63
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	653	825	313	913	903	869	891	893	946	927	1,047
Invested Capital Turnover	2.28	1.20	2.30	2.41	1.67	1.35	1.69	2.20	2.12	1.97	1.80
Increase / (Decrease) in Invested Capital	417	172	-512	600	-10	-35	23	2.10	53	-19	121
Enterprise Value (EV)	1,224	1,668	1,571	1,495	2,376	2,059	2,016	2,337	2,825	2,461	1,618
Market Capitalization	1,176	1,496	1,571	1,407	2,391	2,135	2,157	2,482	3,026	2,745	1,896
Book Value per Share	$25.12	$27.25	$32.91	$33.78	$37.50	$38.42	$41.89	$41.91	$46.13	$48.56	$53.52
Tangible Book Value per Share	$7.01	$5.60	$17.92	$13.26	$18.04	$20.26	$24.77	$25.61	$27.77	$30.60	$34.68
Total Capital	795	927	794	1,036	979	974	1,033	1,040	1,150	1,216	1,340
Total Debt	189	273	0.00	211	60	29	0.00	0.00	0.00	0.00	7.00
Total Long-Term Debt	134	261	0.00	188	59	29	0.00	0.00	0.00	0.00	0.00
Net Debt	48	171	0.00	88	-16	-76	-142	-147	-204	-289	-286
Capital Expenditures (CapEx)	26	17	28	30	31	30	36	42	77	62	74
Debt-free, Cash-free Net Working Capital (DFCFNWC)	166	168	-5.20	267	252	209	250	320	311	296	359
Debt-free Net Working Capital (DFNWC)	308	270	-5.20	391	328	314	392	467	514	585	652
Net Working Capital (NWC)	253	258	-5.20	367	327	314	392	467	514	585	645
Net Nonoperating Expense (NNE)	3.14	-3.86	-1.50	1.23	-0.37	-4.34	-1.59	1.95	-10	118	-7.26
Net Nonoperating Obligations (NNO)	48	171	-481	88	-16	-76	-142	-147	-204	-289	-286
Total Depreciation and Amortization (D&A)	35	38	50	50	48	46	43	40	39	44	44
Debt-free, Cash-free Net Working Capital to Revenue	16.42%	19.02%	-0.40%	18.11%	16.66%	17.48%	16.83%	16.28%	15.93%	16.04%	20.19%
Debt-free Net Working Capital to Revenue	30.42%	30.55%	-0.40%	26.44%	21.66%	26.30%	26.39%	23.77%	26.39%	31.71%	36.64%
Net Working Capital to Revenue	24.95%	29.21%	-0.40%	24.87%	21.60%	26.30%	26.39%	23.77%	26.39%	31.71%	36.25%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.96	$3.39	$2.56	$3.48	$4.58	$1.17	$3.78	$5.37	$5.60	$1.43	$4.69
Adjusted Weighted Average Basic Shares Outstanding	24.11M	24.00M	24.15M	24.40M	24.48M	24.56M	24.65M	24.79M	24.85M	24.93M	24.88M
Adjusted Diluted Earnings per Share	$4.86	$3.33	$2.52	$3.45	$4.54	$1.16	$3.75	$5.32	$5.56	$1.42	$4.67
Adjusted Weighted Average Diluted Shares Outstanding	24.61M	24.44M	24.49M	24.60M	24.73M	24.78M	24.85M	24.98M	25.02M	25.12M	24.99M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	24.01M	24.07M	24.35M	24.43M	24.51M	24.60M	24.77M	24.77M	24.87M	24.96M	24.78M
Normalized Net Operating Profit after Tax (NOPAT)	91	70	88	91	112	54	90	135	129	156	132
Normalized NOPAT Margin	8.96%	7.93%	6.70%	6.15%	7.39%	4.53%	6.08%	6.87%	6.61%	8.48%	7.42%
Pre Tax Income Margin	15.04%	11.67%	9.80%	8.91%	9.94%	3.33%	9.06%	9.40%	8.95%	2.23%	7.77%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	12.47%	73.68%	30.10%	25.53%	22.28%	89.20%	30.93%	23.83%	25.23%	108.99%	36.36%
Augmented Payout Ratio	25.27%	84.01%	31.88%	27.18%	24.42%	96.52%	31.79%	28.27%	26.02%	110.96%	56.86%

This table displays calculated financial ratios and metrics derived from Innospec's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	24,777,859.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	24,777,859.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.23
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-9.53%	-3.13%	-1.84%	-9.45%	-4.46%	-5.64%	-11.88%	1.08%	-0.34%	-2.40%	2.81%
EBITDA Growth	-4.55%	-0.74%	17.78%	12.61%	-6.01%	-274.26%	-16.82%	-23.53%	-59.59%	161.42%	-8.75%
EBIT Growth	-5.08%	-3.10%	19.02%	12.74%	-9.85%	-339.73%	-21.05%	-29.81%	-77.91%	146.10%	-8.64%
NOPAT Growth	-12.79%	41.24%	24.98%	7.60%	-1.68%	-22.52%	-16.96%	-13.04%	-80.53%	53.29%	-10.82%
Net Income Growth	1.29%	48.24%	24.70%	7.96%	-14.80%	-286.24%	-20.77%	-24.68%	-61.38%	167.33%	-8.33%
EPS Growth	1.29%	47.06%	24.06%	6.90%	-15.29%	-286.67%	-20.61%	-24.19%	-60.90%	167.86%	-6.87%
Operating Cash Flow Growth	45.98%	-7.65%	269.72%	-91.45%	26.51%	-64.50%	-64.89%	97.87%	-46.53%	138.91%	-37.81%
Free Cash Flow Firm Growth	319.60%	-163.94%	-38.25%	-97.63%	-89.44%	408.84%	-133.58%	-2,488.35%	-836.11%	-259.93%	-293.94%
Invested Capital Growth	-7.11%	5.89%	-1.82%	2.89%	2.49%	-2.01%	5.44%	8.29%	9.36%	13.00%	10.34%
Revenue Q/Q Growth	-3.39%	6.59%	1.11%	-13.03%	1.93%	5.28%	-5.57%	-0.25%	0.50%	3.10%	-0.53%
EBITDA Q/Q Growth	20.94%	-4.59%	17.78%	-17.14%	0.95%	-276.88%	156.22%	-23.82%	-46.65%	168.84%	-15.22%
EBIT Q/Q Growth	26.56%	-6.21%	21.46%	-21.80%	1.20%	-349.41%	140.00%	-30.48%	-68.15%	420.43%	-19.21%
NOPAT Q/Q Growth	28.05%	7.39%	1.82%	-23.14%	16.99%	-15.37%	9.13%	-19.52%	-73.81%	566.37%	-36.11%
Net Income Q/Q Growth	35.64%	-3.57%	9.52%	-24.64%	7.05%	-310.78%	146.59%	-28.35%	-45.11%	267.44%	-35.02%
EPS Q/Q Growth	35.34%	-4.46%	10.00%	-24.85%	7.26%	-310.53%	146.79%	-28.24%	-44.68%	265.38%	-35.79%
Operating Cash Flow Q/Q Growth	5.64%	24.61%	11.33%	-94.17%	1,463.83%	-65.03%	10.12%	-67.14%	322.58%	56.23%	-71.34%
Free Cash Flow Firm Q/Q Growth	10.26%	-114.72%	454.33%	-95.88%	391.40%	330.50%	-138.53%	-193.05%	-51.45%	6.47%	6.12%
Invested Capital Q/Q Growth	-0.86%	2.71%	-3.15%	4.32%	-1.25%	-1.79%	4.21%	7.14%	-0.27%	1.48%	1.76%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	29.56%	31.47%	31.13%	29.17%	27.99%	29.18%	28.38%	28.02%	26.41%	27.96%	27.25%
EBITDA Margin	12.20%	10.92%	12.71%	12.11%	12.00%	-20.16%	12.00%	9.17%	4.87%	12.69%	10.81%
Operating Margin	9.03%	9.00%	10.10%	9.36%	10.28%	8.80%	9.64%	7.80%	1.34%	10.27%	8.05%
EBIT Margin	10.06%	8.85%	10.64%	9.56%	9.49%	-22.49%	9.53%	6.64%	2.10%	10.62%	8.63%
Profit (Net Income) Margin	8.45%	7.64%	8.28%	7.17%	7.53%	-15.08%	7.44%	5.34%	2.92%	10.40%	6.80%
Tax Burden Percent	82.53%	83.44%	74.86%	71.40%	74.55%	68.62%	73.87%	73.67%	112.17%	94.23%	77.19%
Interest Burden Percent	101.71%	103.42%	103.95%	105.05%	106.41%	97.71%	105.71%	109.25%	123.66%	103.93%	102.05%
Effective Tax Rate	17.47%	16.56%	25.14%	28.60%	25.45%	0.00%	26.13%	26.33%	-12.17%	5.77%	22.81%
Return on Invested Capital (ROIC)	15.31%	15.91%	15.85%	13.43%	15.41%	12.15%	13.52%	10.34%	2.71%	17.44%	10.96%
ROIC Less NNEP Spread (ROIC-NNEP)	12.31%	15.53%	14.13%	12.37%	15.64%	52.39%	13.03%	11.04%	0.53%	16.29%	10.06%
Return on Net Nonoperating Assets (RNNOA)	-1.71%	-2.49%	-2.60%	-2.19%	-3.36%	-10.91%	-3.03%	-2.24%	-0.12%	-3.67%	-2.25%
Return on Equity (ROE)	13.60%	13.42%	13.25%	11.23%	12.04%	1.23%	10.49%	8.10%	2.59%	13.76%	8.70%
Cash Return on Invested Capital (CROIC)	19.83%	8.30%	16.60%	11.86%	12.33%	18.45%	10.80%	9.18%	-0.17%	-1.13%	0.58%
Operating Return on Assets (OROA)	12.03%	10.42%	12.29%	10.94%	10.41%	-24.12%	9.70%	6.78%	2.09%	10.59%	8.59%
Return on Assets (ROA)	10.10%	8.99%	9.56%	8.21%	8.26%	-16.17%	7.58%	5.46%	2.90%	10.37%	6.77%
Return on Common Equity (ROCE)	13.57%	13.39%	13.22%	11.20%	12.01%	1.23%	10.46%	8.07%	2.58%	13.70%	8.66%
Return on Equity Simple (ROE_SIMPLE)	11.27%	0.00%	12.45%	12.54%	11.57%	0.00%	2.14%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	35	37	38	29	34	29	31	25	6.62	44	28
NOPAT Margin	7.45%	7.51%	7.56%	6.68%	7.67%	6.16%	7.12%	5.75%	1.50%	9.68%	6.22%
Net Nonoperating Expense Percent (NNEP)	3.00%	0.38%	1.72%	1.05%	-0.23%	-40.24%	0.49%	-0.70%	2.19%	1.15%	0.90%
Return On Investment Capital (ROIC_SIMPLE)	-	3.23%	-	-	-	2.37%	2.48%	1.94%	0.51%	3.29%	2.08%
Cost of Revenue to Revenue	70.44%	68.53%	68.87%	70.83%	72.01%	70.82%	71.62%	71.98%	73.59%	72.04%	72.75%
SG&A Expenses to Revenue	18.03%	20.68%	18.53%	16.87%	15.07%	17.37%	15.72%	16.97%	16.27%	15.21%	17.32%
R&D to Revenue	2.50%	1.80%	2.36%	2.80%	2.50%	2.72%	2.88%	3.09%	3.10%	2.41%	2.91%
Operating Expenses to Revenue	20.53%	22.48%	21.03%	19.82%	17.70%	20.37%	18.74%	20.22%	25.07%	17.69%	19.20%
Earnings before Interest and Taxes (EBIT)	47	44	53	42	42	-105	42	29	9.30	48	39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	57	54	64	53	53	-94	53	40	22	58	49
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.23	2.64	2.69	2.58	2.27	2.27	1.88	1.62	1.48	1.43	1.35
Price to Tangible Book Value (P/TBV)	3.49	4.38	4.38	4.15	3.58	3.60	2.96	2.56	2.30	2.21	2.06
Price to Revenue (P/Rev)	1.28	1.55	1.64	1.63	1.51	1.49	1.32	1.17	1.07	1.07	1.01
Price to Earnings (P/E)	19.79	21.76	21.64	20.60	19.61	77.11	87.59	108.75	0.00	16.26	15.84
Dividend Yield	1.33%	1.16%	1.10%	1.20%	1.31%	1.41%	1.64%	1.94%	2.11%	2.23%	2.34%
Earnings Yield	5.05%	4.60%	4.62%	4.85%	5.10%	1.30%	1.14%	0.92%	0.00%	6.15%	6.31%
Enterprise Value to Invested Capital (EV/IC)	2.50	2.99	3.19	2.98	2.67	2.65	2.14	1.78	1.60	1.54	1.44
Enterprise Value to Revenue (EV/Rev)	1.17	1.45	1.51	1.50	1.35	1.33	1.16	1.03	0.92	0.91	0.85
Enterprise Value to EBITDA (EV/EBITDA)	10.88	13.36	13.21	12.54	11.28	32.64	32.01	35.15	80.16	9.38	9.12
Enterprise Value to EBIT (EV/EBIT)	13.29	16.42	16.17	15.35	13.95	77.14	100.04	221.49	0.00	12.55	12.22
Enterprise Value to NOPAT (EV/NOPAT)	19.36	21.92	21.40	20.54	18.29	16.01	13.68	10.78	19.05	14.80	14.46
Enterprise Value to Operating Cash Flow (EV/OCF)	10.81	13.63	10.97	13.18	10.90	13.34	15.66	13.44	16.09	11.70	11.99
Enterprise Value to Free Cash Flow (EV/FCFF)	12.16	37.03	19.03	25.46	21.93	14.25	20.38	20.12	0.00	0.00	258.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.14	-0.16	-0.18	-0.18	-0.22	-0.21	-0.23	-0.20	-0.23	-0.23	-0.22
Leverage Ratio	1.48	1.51	1.48	1.45	1.44	1.46	1.43	1.40	1.41	1.40	1.37
Compound Leverage Factor	1.51	1.56	1.54	1.52	1.53	1.42	1.51	1.53	1.74	1.45	1.40
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.52%	0.20%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.52%	0.20%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.24%	0.22%	0.22%	0.28%	0.34%	0.40%	0.45%	0.47%	0.45%	0.51%	0.53%
Common Equity to Total Capital	99.76%	99.78%	99.78%	99.72%	99.66%	99.60%	99.55%	99.53%	99.55%	98.97%	99.27%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.02
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.66	-1.71
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.03
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-2.61	-2.71
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	5.64	5.69	5.96	6.13	5.46	5.27	5.13	4.78	4.58	4.60	4.68
Noncontrolling Interest Sharing Ratio	0.23%	0.22%	0.22%	0.26%	0.29%	0.31%	0.34%	0.38%	0.40%	0.46%	0.49%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.51	2.38	2.50	2.63	2.59	2.58	2.73	2.87	2.78	2.79	2.98
Quick Ratio	1.49	1.52	1.61	1.62	1.69	1.70	1.80	1.79	1.74	1.76	1.92
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	105	-15	55	2.26	11	48	-18	-54	-82	-76	-72
Operating Cash Flow to CapEx	347.90%	343.13%	563.64%	30.92%	628.21%	124.76%	182.58%	57.41%	177.03%	299.51%	128.47%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.20	1.18	1.16	1.14	1.10	1.07	1.02	1.02	0.99	1.00	1.00
Accounts Receivable Turnover	6.07	5.61	5.87	6.20	5.92	5.26	5.40	5.63	5.28	5.20	5.13
Inventory Turnover	3.86	4.03	4.00	3.93	4.03	4.33	4.11	3.94	3.88	4.08	4.08
Fixed Asset Turnover	8.71	7.97	7.72	7.37	7.17	6.86	6.54	6.31	6.43	6.40	6.36
Accounts Payable Turnover	8.62	8.26	7.79	8.63	8.32	7.96	7.58	8.63	7.78	7.60	8.44
Days Sales Outstanding (DSO)	60.16	65.03	62.16	58.89	61.65	69.37	67.61	64.86	69.06	70.21	71.12
Days Inventory Outstanding (DIO)	94.48	90.49	91.22	92.77	90.60	84.22	88.79	92.57	94.15	89.48	89.44
Days Payable Outstanding (DPO)	42.35	44.21	46.85	42.30	43.87	45.87	48.13	42.29	46.93	48.05	43.25
Cash Conversion Cycle (CCC)	112.30	111.31	106.54	109.36	108.38	107.72	108.28	115.14	116.29	111.63	117.31
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	921	946	916	956	944	927	966	1,035	1,032	1,047	1,066
Invested Capital Turnover	2.05	2.12	2.10	2.01	2.01	1.97	1.90	1.80	1.81	1.80	1.76
Increase / (Decrease) in Invested Capital	-71	53	-17	27	23	-19	50	79	88	121	100
Enterprise Value (EV)	2,305	2,825	2,920	2,845	2,521	2,461	2,071	1,838	1,651	1,618	1,530
Market Capitalization	2,510	3,026	3,187	3,081	2,821	2,745	2,365	2,099	1,916	1,896	1,809
Book Value per Share	$45.26	$46.13	$47.55	$47.83	$49.85	$48.56	$50.48	$51.90	$52.23	$53.52	$54.28
Tangible Book Value per Share	$28.94	$27.77	$29.26	$29.80	$31.57	$30.60	$32.00	$32.83	$33.58	$34.68	$35.39
Total Capital	1,128	1,150	1,186	1,196	1,248	1,216	1,266	1,302	1,303	1,340	1,355
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.00	2.70
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-207	-204	-270	-240	-304	-289	-300	-267	-271	-286	-286
Capital Expenditures (CapEx)	17	21	14	15	12	21	16	16	22	21	14
Debt-free, Cash-free Net Working Capital (DFCFNWC)	312	311	278	304	289	296	320	366	362	359	378
Debt-free Net Working Capital (DFNWC)	520	514	548	544	593	585	620	632	633	652	667
Net Working Capital (NWC)	520	514	548	544	593	585	620	632	633	645	664
Net Nonoperating Expense (NNE)	-4.62	-0.67	-3.59	-2.14	0.60	99	-1.40	1.77	-6.28	-3.30	-2.62
Net Nonoperating Obligations (NNO)	-207	-204	-270	-240	-304	-289	-300	-267	-271	-286	-286
Total Depreciation and Amortization (D&A)	9.90	10	10	11	11	11	11	11	12	9.40	9.90
Debt-free, Cash-free Net Working Capital to Revenue	15.89%	15.93%	14.33%	16.04%	15.41%	16.04%	17.90%	20.42%	20.23%	20.19%	21.11%
Debt-free Net Working Capital to Revenue	26.44%	26.39%	28.26%	28.72%	31.63%	31.71%	34.69%	35.31%	35.36%	36.64%	37.25%
Net Working Capital to Revenue	26.44%	26.39%	28.26%	28.72%	31.63%	31.71%	34.69%	35.31%	35.36%	36.25%	37.10%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.58	$1.52	$1.66	$1.25	$1.34	($2.82)	$1.31	$0.94	$0.52	$1.92	$1.23
Adjusted Weighted Average Basic Shares Outstanding	24.87M	24.85M	24.89M	24.94M	24.94M	24.93M	24.97M	24.94M	24.83M	24.88M	24.78M
Adjusted Diluted Earnings per Share	$1.57	$1.50	$1.65	$1.24	$1.33	($2.80)	$1.31	$0.94	$0.52	$1.90	$1.22
Adjusted Weighted Average Diluted Shares Outstanding	25.01M	25.02M	25.07M	25.10M	25.10M	25.12M	25.10M	25.04M	24.91M	24.99M	24.84M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	24.87M	24.87M	24.93M	24.94M	24.94M	24.96M	24.96M	24.83M	24.78M	24.78M	24.63M
Normalized Net Operating Profit after Tax (NOPAT)	35	37	38	29	34	30	32	26	22	44	25
Normalized NOPAT Margin	7.45%	7.51%	7.66%	6.78%	7.77%	6.36%	7.22%	5.86%	4.93%	9.74%	5.42%
Pre Tax Income Margin	10.23%	9.16%	11.06%	10.05%	10.10%	-21.98%	10.07%	7.25%	2.60%	11.04%	8.80%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	26.26%	25.23%	0.00%	24.67%	25.66%	108.99%	0.00%	210.36%	-3,383.33%	36.36%	37.26%
Augmented Payout Ratio	27.76%	26.02%	0.81%	25.20%	26.22%	110.96%	18.89%	279.27%	-5,375.00%	56.86%	60.28%

Financials Breakdown Chart

Key Financial Trends

Below is a concise, data-driven read on Innospec Inc. (NASDAQ: IOSP) using the last four years of quarterly statements provided. The focus is on identifying trends in revenue, profitability, cash flow, and balance-sheet health to help retail investors gauge how the business has been performing and where it might be headed.

Strong near-term cash generation. In Q4 2025, net cash from continuing operating activities was $61.4 million, indicating solid cash generation from core operations.
Positive free cash flow in latest quarter. With ~\$21.2 million of capex in Q4 2025, the approximate quarterly free cash flow is around \$40 million (61.4 - 21.2 = 40.2), suggesting cash can fund dividends and debt reduction without additional financing.
Earnings rebound in the latest quarter. Net income from continuing operations for Q4 2025 was about \$47.4 million, a rebound after the prior-year period.
Per-share earnings remain solid in Q4 2025. Basic EPS of \$1.92 and Diluted EPS of \$1.90 in Q4 2025 reflect meaningful profitability on a per-share basis.
Consistent dividend policy. Cash dividends per share have been around \$0.84 in recent periods, signaling ongoing capital return to shareholders.
Balance-sheet liquidity around a steady range. Cash & equivalents have trended in the \$270–\$300 million range across 2024–2025 (e.g., ~\$270.8M in Q3 2025 and \$299.8M in Q1 2025), supporting near-term liquidity.
Steady, constructive equity base. Total equity has remained robust, around \$1.1–\$1.3 billion, providing a solid capitalization base to weather cyclicality.
Gross margin has contracted over the four-year view. Gross margin declined from roughly 31% in late-2023 to about 28% in Q4 2025, indicating margin pressure as input costs or product mix shift.
Revenue trend is down modestly from the peak earlier in the period. Revenue moved from around \$510.7 million in Q4 2022 down to about \$455.6 million in Q4 2025, an approximate decline of 11% over four years.
Profitability has shown volatility across years. Revenue and earnings swing—from a hefty quarterly loss in 2024 (e.g., Q4 2024 net income of about -\$70.4 million) to a positive reported quarter in 2025 (Q4 net income of ~\$47.4 million)—highlighting earnings volatility that may warrant caution.
Big impairment in 2025 the third quarter. An impairment charge of \$42 million occurred in Q3 2025, weighing on profitability in that period.

05/14/26 12:41 PM ETAI Generated. May Contain Errors.

Innospec Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Innospec's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Innospec's net income were at $116.60 million at the end of 2025, a 227.5% increase from 2024, and a 2.4% decrease since 2015. See Innospec's forecast for analyst expectations on what's next for the company.

Innospec's total operating income in 2025 was $129.50 million, based on the following breakdown:

Total Gross Profit: $492.40 million
Total Operating Expenses: $362.90 million

Over the last 10 years, Innospec's total revenue changed from $1.01 billion in 2015 to $1.78 billion in 2025, a change of 75.6%.

Innospec's total liabilities were at $499.50 million at the end of 2025, a 3.7% decrease from 2024, and a 18.0% increase since 2015.

In the past 10 years, Innospec's cash and equivalents has ranged from $0.00 in 2017 to $292.50 million in 2025, and is currently $292.50 million as of their latest financial filing in 2025.

Over the last 10 years, Innospec's book value per share changed from 25.12 in 2015 to 53.52 in 2025, a change of 113.0%.

Related Companies

Financial statements for NASDAQ:IOSP last updated on 5/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Innospec (IOSP) Financials

Financials Breakdown Chart

Key Financial Trends

Innospec Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Innospec (IOSP) Financials

Annual Income Statements for Innospec

Quarterly Income Statements for Innospec

Annual Cash Flow Statements for Innospec

Quarterly Cash Flow Statements for Innospec

Annual Balance Sheets for Innospec

Quarterly Balance Sheets for Innospec

Annual Metrics And Ratios for Innospec

Quarterly Metrics And Ratios for Innospec

Financials Breakdown Chart

Key Financial Trends

Innospec Financials - Frequently Asked Questions

When does Innospec's fiscal year end?

How has Innospec's net income changed over the last 10 years?

What is Innospec's operating income?

How has Innospec's revenue changed over the last 10 years?

How much debt does Innospec have?

How much cash does Innospec have?

How has Innospec's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools